Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokers.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 12529350.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Expression of retinoic acid receptor beta (RAR beta) and telomerase catalytic subunit (human telomerase reverse transcriptase [hTERT]) was analyzed in 285 bronchial biopsy specimens from 53 heavy cigarette smokers and four former smokers by using in situ hybridization. Of the 191 biopsy specimens that were positive for RAR beta, 69% expressed hTERT, whereas only 54% of the 94 RAR beta negative biopsy specimens expressed hTERT (P =.014). Because hTERT expression in bronchial tissue has been previously associated with increased risk of lung cancer, the association between RAR beta and hTERT expression suggests that RAR beta expression may be an indicator of increased risk of lung cancer in heavy smokers.
Medical subject headings
- Biomarkers, Tumor
- Bronchi
- Lung Neoplasms
- Receptors, Retinoic Acid
- Respiratory Mucosa
- Smoking
- Telomerase